Stevanato Group, Aptar Pharma Collaborate on Syringe Selection
Stevanato Group and Aptar Pharma announced a collaboration to provide system-level data supporting pre-filled syringe system selection.
Related stories
Shengyi Electronics Q3 Net Profit Rises 37.1% Year Over Year
M impact | EQUITY | Oct 29, 2026, 12:17 PM UTC
Intellinetics to Host Q3 2026 Financial Results Call Nov. 12
M impact | EQUITY | Oct 29, 2026, 12:17 PM UTC
Anker Innovations Says Q3 Revenue Rose 17% Year Over Year
Anker Innovations said third-quarter revenue increased 17% year over year.
M impact | EQUITY | Oct 29, 2026, 12:17 PM UTC
Software Stocks Slide After Fortinet and ServiceNow Results
Software shares tumbled in premarket trading after disappointing results from Fortinet and ServiceNow, deepening concerns about AI disruption in the sector.
M impact | EQUITY | Oct 29, 2026, 12:16 PM UTC
Leonardo DRS Reports Higher Q3 Adjusted Earnings and Revenue, Raises 2026 Guidance
Leonardo DRS reported higher Q3 adjusted earnings and revenue and raised its 2026 guidance.
M impact | EQUITY | Oct 29, 2026, 12:16 PM UTC
CACI Wins Five-Year U.S. Army Task Order Valued at Up to $185 Million
CACI says the task order supports the Army's Program Manager Expeditionary Energy and Sustainment Systems. The company will develop and integrate expeditionary power capabilities.
M impact | EQUITY | Oct 29, 2026, 12:16 PM UTC